W. Gooding

T. Godfrey, R. Ferris, W. Gooding, 2013, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Elective Neck Dissection and Survival in Patients With Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

R. Ferris, U. Duvvuri, E. Myers, 2004, The Laryngoscope.

Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck*

J. Grandis, S. Xi, T. Smithgall, 2003, Journal of Biological Chemistry.

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation

D. Bigner, J. Grandis, S. Lai, 2009, Oncogene.

Reoperative antireflux surgery for failed fundoplication: an analysis of outcomes in 275 patients.

J. Luketich, R. Landreneau, A. Pennathur, 2011, The Annals of thoracic surgery.

Roux-en-Y near esophagojejunostomy for failed antireflux operations: outcomes in more than 100 patients.

J. Luketich, R. Landreneau, Ryan M. Levy, 2014, The Annals of thoracic surgery.

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer

Kelsey P. Pendleton, J. Grandis, Daniel E. Johnson, 2016, PloS one.

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

R. Seethala, Lin Wang, J. Grandis, 2011, Oral oncology.

Antitumor Mechanisms of Systemically Administered Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck

J. Grandis, S. Strychor, W. Zamboni, 2008, Molecular Pharmacology.

Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed.

Simion I. Chiosea, R. Seethala, R. Ferris, 2013, Oral oncology.

IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.

A. Egloff, Lin Wang, J. Grandis, 2017, Oral oncology.

Randomized, placebo-controlled window trial of EGFR, Src, or combined blockade in head and neck cancer.

Simion I. Chiosea, G. Mills, A. Jimeno, 2017, JCI insight.

Phase 1 study of EGFR‐antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

D. Heron, J. Grandis, Seungwon Kim, 2018, Cancer.

Dual Blockade of EGFR and c-Met Abrogates Redundant Signaling and Proliferation in Head and Neck Carcinoma Cells

J. Siegfried, J. Grandis, Hai-Yan Xu, 2011, Clinical Cancer Research.

Evaluation of computerized tomography for staging of clinically localized adenocarcinoma of the prostate.

R. Bahnson, B. Konety, W. Gooding, 1996, Urologic oncology.

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

M. Romkes, R. Seethala, Lin Wang, 2011, Clinical Cancer Research.

Predictive Biomarkers and Personalized Medicine XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

M. Romkes, R. Seethala, Lin Wang, 2011 .

Transoral endoscopic repair of Zenker diverticulum by a thoracic surgical service.

J. Luketich, Ryan M. Levy, A. Pennathur, 2021, Journal of Thoracic and Cardiovascular Surgery.

Biliary palliation for unresectable pancreatic adenocarcinoma: surgical bypass or self-expanding metal stent?

Alessandra Storino, Ammara A Watkins, A. Moser, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

The pathogenesis of disseminated intravascular coagulation in sepsis.

J. Kirkwood, M. Ernstoff, W. Gooding, 1994, JAMA.

Defects in the Human Leukocyte Antigen Class I Antigen Processing Machinery in Head and Neck Squamous Cell Carcinoma: Association with Clinical Outcome

B. Seliger, T. Whiteside, S. Ferrone, 2005, Clinical Cancer Research.

Defects in the Human LeukocyteAntigen Class I Antigen-Processing Machinery in Head and Neck Squamous Cell Carcinoma : Associationwith Clinical Outcome

B. Seliger, T. Whiteside, S. Ferrone, 2005 .

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

R. Ferris, T. Whiteside, J. Hunt, 2005, Cancer research.

Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer.

J. Grandis, R. Ferris, A. Argiris, 2012, Oral oncology.

A Combination of Molecular Markers Accurately Detects Lymph Node Metastasis in Non–Small Cell Lung Cancer Patients

Tony E Godfrey, T. Godfrey, J. Luketich, 2006, Clinical Cancer Research.

Multicenter outcomes of robotic reconstruction during the early learning curve for minimally-invasive pancreaticoduodenectomy.

Ugo Boggi, Herbert J Zeh, U. Boggi, 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Cancer Therapy : Clinical Phase I Dendritic Cell p 53 Peptide Vaccine for Head and Neck Cancer

Eld, R. Ferris, A. Argiris, 2014 .

Phase II trial of pemetrexed and bevacizumab in patients with recurrent or metastatic head and neck cancer.

S. Zhong, M. Karamouzis, M. Romkes, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer.

D. Heron, R. Seethala, Lin Wang, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms.

G. Mills, J. Mountz, A. Egloff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ectopic Expression of Interferon Regulatory Factor-1 Promotes Human Breast Cancer Cell Death and Results in Reduced Expression of Survivin

Simon C Watkins, A. Gambotto, M. Stang, 2004, Cancer Research.

Novel Immunogenic HLA-A*0201-restricted Epidermal Growth Factor Receptor-specific T-cell Epitope in Head and Neck Cancer Patients

R. Ferris, W. Gooding, P. A. Andrade Filho, 2010, Journal of immunotherapy.

Durable complete responses with high-dose bolus interleukin-2 in patients with metastatic melanoma who have experienced progression after biochemotherapy.

J. Kirkwood, W. Gooding, S. Agarwala, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.

T. Whiteside, W. Gooding, T. Tsukishiro, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck

T. Whiteside, W. Gooding, Jonas T. Johnson, 2007, Clinical Cancer Research.

First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012, Cancer discovery.

Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma

J. Kirkwood, S. Moschos, C. Sander, 2012, Journal of immunotherapy.

Association of Epstein-Barr virus with tumor cell proliferation: clinical implication in nasopharyngeal carcinoma.

W. Gooding, N. Kinukawa, M. Uno, 2001, International Journal of Oncology.

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck

R. Day, T. Whiteside, E. Myers, 1991, Head & neck.

Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.

M. Posner, R. Landreneau, B. Lembersky, 1998, The cancer journal from Scientific American.

Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing.

William A. Mcmillan, Wendy Wong, Tony E Godfrey, 2005, Clinical chemistry.

Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma

J. Kirkwood, C. Sander, M. Panelli, 2022, Cancers.

The gender gap in a surgical subspecialty: analysis of career and lifestyle factors.

S. Mackinnon, J. Grandis, M. Wagener, 2004, Archives of otolaryngology--head & neck surgery.

Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy

T. Godfrey, R. Seethala, R. Ferris, 2012, The Laryngoscope.

Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.

J. Mountz, D. Heron, M. Karamouzis, 2009, International journal of radiation oncology, biology, physics.

Spontaneous Apoptosis of CD 8 1 T Lymphocytes in Peripheral Blood of Patients with Advanced Melanoma 1

M. Lotze, T. Whiteside, Takao Saito, 2000 .

Phase II trial of high-dose bolus (HDB) IL-2 in patients with metastatic melanoma (MM) who haveprogressed after biochemotherapy (BCT): Updated results

J. Kirkwood, W. Gooding, S. Agarwala, 2005 .

Carcinoma of the Head and Neck Cells to In Vitro Resistance of Squamous Cell Role of Antigen-Processing Machinery in the

Soldano Ferrone, Robert L. Ferris, Avinash Machandia, 2013 .

Chain Expression and Apoptosis in CD 3 + Peripheral Blood T Lymphocytes of Patients with Melanoma

M. Lotze, T. Whiteside, G. Dworacki, 2007 .

Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell‐Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice

W. Gooding, Q. Cai, J. Baar, 2009, Clinical and translational science.

Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma.

T. Whiteside, W. Gooding, 2003, Blood cells, molecules & diseases.

Type‐1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8+ T cells against prostate cancer cells and defined prostate cancer‐specific epitopes

J. Banchereau, K. Palucka, G. Chatta, 2011, The Prostate.

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

R. Day, J. Kirkwood, R. Bahnson, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer Therapy : Clinical Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen – Speci fi c T-cell Immunity in Head and Neck Cancer Patients

R. Ferris, S. Ferrone, Christopher A. Lord, 2013 .

Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma

J. Grandis, A. Argiris, J. Bauman, 2016, Head & neck.

Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases

R. Ferris, E. Siegel, A. Lokshin, 2008, Proteomics. Clinical applications.

Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.

J. Kirkwood, R. Shadduck, W. Gooding, 1996, Experimental hematology.

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Simion I. Chiosea, J. Siegfried, Lin Wang, 2014, Clinical Cancer Research.

Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.

T. Whiteside, G. Dworacki, W. Gooding, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy

T. Whiteside, W. Szyfter, G. Dworacki, 2013, European Archives of Oto-Rhino-Laryngology.

STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma

Lin Wang, J. Grandis, Hua Li, 2016, Cancer Prevention Research.

STAT 3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma

Lin Wang, J. Grandis, Hua Li, 2016 .

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer

Simion I. Chiosea, G. Mills, S. Vandenberg, 2019, The Journal of experimental medicine.

Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion.

J. Kirkwood, R. Hammond, B. Lembersky, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets

T. Whiteside, M. Mitsuhashi, P. Simms, 2016, Scientific Reports.

Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer

T. Godfrey, R. Seethala, R. Ferris, 2011, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis Intraoperative qRT-PCR for Detection of Lymph Node Metastasis in Head and Neck Cancer

T. Godfrey, R. Seethala, R. Ferris, 2011 .

Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer.

S. Ramalingam, S. Ramalingam, Yan Lin, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?

R. Ferris, W. Gooding, Andrew B. Tassler, 2019, Head & neck.

PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV‐Related Oropharyngeal Cancer

R. Ferris, Seungwon Kim, T. Rath, 2021, The Laryngoscope.

Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.

D. Heron, J. Johnson, R. Ferris, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Protein Signatures and Tissue Diagnosis of Pancreatic Cancer.

C. Forsmark, S. Hughes, J. Trevino, 2020, Journal of the American College of Surgeons.

The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.

R. Ferris, J. Maxwell, B. Branstetter, 2011, Archives of otolaryngology--head & neck surgery.

Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.

R. Ferris, T. Whiteside, W. Gooding, 2005, Advances in oto-rhino-laryngology.

Electromagnetic Navigation Bronchoscopy-Guided Dye Marking for Thoracoscopic Resection of Pulmonary Nodules.

Arjun Pennathur, J. Luketich, A. Pennathur, 2016, The Annals of thoracic surgery.

First-inHuman Trial of a STAT 3 Decoy Oligonucleotide in Head and Neck Tumors : Implications for Cancer Therapy

Simion I. Chiosea, Joanne I. Yeh, D. Ly, 2012 .

Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes

J. Siegfried, R. Seethala, J. Grandis, 2008, Clinical Cancer Research.

Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) gene therapy protection of the esophagus from chemoradiotherapy damage during treatment of locally unresectable non-small-cell lung cancer (NSCLC).

J. Luketich, J. Greenberger, C. Belani, 2000, Clinical lung cancer.

Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole.

J. Grandis, D. Smith, D. Trump, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Photodynamic Therapy with Curative Intent for Barrett’s Esophagus with High Grade Dysplasia and Superficial Esophageal Cancer

J. Luketich, R. Landreneau, A. Pennathur, 2007, Annals of Surgical Oncology.

The Role of Topical Antibiotic Prophylaxis in Patients Undergoing Contaminated Head and Neck Surgery With Flap Reconstruction

J. Grandis, J. Simons, E. Myers, 2001, The Laryngoscope.

Correlation of anti-tumor adaptive immunity with clinical response in a phase II "Window" trial of neoadjuvant cetuximab in patients with resectable stage III-IV head and neck squamous carcinoma (HNSCC).

D. Heron, R. Ferris, Seungwon Kim, 2016 .

Temporal patterns of head and neck squamous cell carcinoma recurrence with positron‐emission tomography/computed tomography monitoring

B. Branstetter, W. Gooding, Jonas T. Johnson, 2012, The Laryngoscope.

Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story

T. Hensing, J. Kolesar, A. Argiris, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss

S. Gollin, W. Saunders, W. Gooding, 2014, Genes, chromosomes & cancer.

Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma.

M. Stang, Pierre E Queiroz de Oliveira, S. Hughes, 2006, Neoplasia.

Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival

T. Whiteside, M. Mitsuhashi, H. Okada, 2015, Oncoimmunology.

Evaluation of electromagnetic navigational bronchoscopic biopsy of lung lesions performed by a thoracic surgical service.

J. Luketich, A. Pennathur, O. Awais, 2023, Surgery.

Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?

S. Mandel, Y. Nikiforov, D. Steward, 2021, Thyroid : official journal of the American Thyroid Association.

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

R. Seethala, M. Nikiforova, Y. Nikiforov, 2021, Cancer.

A phase II study of arsenic trioxide (ATO) in patients with metastatic melanoma

J. Kirkwood, W. Gooding, S. Agarwala, 2007 .

Expression of zeta in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma.

T. Whiteside, R. Edwards, W. Gooding, 2002, Cancer biotherapy & radiopharmaceuticals.

A phase 2 trial of sequential temozolomide chemotherapy followed by high‐dose interleukin 2 immunotherapy for metastatic melanoma

J. Kirkwood, S. Moschos, W. Gooding, 2008, Cancer.

Phase 2a Study of Cetuximab and Dasatinib in Patients With Cetuximab-Resistant Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

A. Egloff, J. Grandis, J. Bauman, 2016 .

Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.

J. Luketich, R. Landreneau, P. Buenaventura, 2005, The Journal of thoracic and cardiovascular surgery.

588 Phase Ib study of the p38 inhibitor ARRY-614 with nivolumab, ipilimumab or nivolumab+ipilimumab in advanced solid tumors

D. Davar, Amy Rose, Y. Najjar, 2022, Regular and Young Investigator Award Abstracts.

Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer.

T. Godfrey, J. Luketich, S. Finkelstein, 2002, Journal of Thoracic and Cardiovascular Surgery.

Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma

J. Kirkwood, H. Tawbi, W. Gooding, 2008, Cancer.

Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma

J. Christensen, M. Stang, Ryan M. Levy, 2006 .

Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.

T. Godfrey, R. Ferris, T. Whiteside, 2005, Clinical immunology.

Reply to Letter: "Poorer Survival for Stage IIa Patients After Minimally Invasive Esophagectomy".

J. Luketich, A. Pennathur, K. Nason, 2015, Annals of surgery.

Skin rash and good performance status (PS) predict improved survival with gefitinib for patients with advanced non-small cell lung cancer (NSCLC).

S. Ramalingam, W. Cronin, C. Belani, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity.

R. Ferris, Seungwon Kim, M. Nilsen, 2021, Oral oncology.

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

D. Davar, Y. Najjar, J. Kirkwood, 2023, Frontiers in Immunology.

Stereotactic radiosurgery for the treatment of lung neoplasm: experience in 100 consecutive patients.

D. Heron, J. Luketich, C. Ozhasoglu, 2009, The Annals of thoracic surgery.

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

J. Grandis, A. Wells, J. Kassis, 2003, Cancer research.

Phase II evaluation of tremelimumab (Treme) combined with high-dose interferon alpha-2b (HDI) for metastatic melanoma.

J. Kirkwood, H. Tawbi, S. Moschos, 2010 .

Myopodin, a synaptopodin homologue, is frequently deleted in invasive prostate cancers.

M. Becich, R. Dhir, Y. Yu, 2001, The American journal of pathology.

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer

S. Ramalingam, C. Belani, W. Gooding, 2010, Cancer.

Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies

Lin Wang, J. Grandis, Hua Li, 2015, Clinical Cancer Research.

Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.

R. Seethala, R. Ferris, C. Van Waes, 2008, Journal of the National Cancer Institute.

Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells.

Jennifer L. Taylor, W. Gooding, W. Storkus, 2012, Cancer research.

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

R. Ferris, J. Moy, S. Lang, 2017, Cancer research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Charles J. Vaske, Joe Y. Chang, Scott R. Presnell, 2016, Journal for ImmunoTherapy of Cancer.

Serum biomarkers as potential predictors of antitumor activity of cetuximab-containing therapy for locally advanced head and neck cancer.

R. Seethala, Lin Wang, J. Grandis, 2011, Oral oncology.

Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients.

D. Heron, J. Luketich, C. Ozhasoglu, 2009, The Journal of thoracic and cardiovascular surgery.

Stereotactic radiosurgery for the treatment of lung neoplasm: initial experience.

D. Heron, J. Luketich, C. Ozhasoglu, 2007, The Annals of thoracic surgery.

Phase II trial of everolimus in patients with previously treated recurrent or metastatic head and neck squamous cell carcinoma

J. Grandis, A. Argiris, J. Bauman, 2016, Head & neck.

Spontaneous apoptosis of tumor‐specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer

T. Whiteside, A. Deleo, A. Albers, 2009, Head & neck.

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Simion I. Chiosea, R. Herbst, Lin Wang, 2016, The Journal of clinical investigation.

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung Cancer

S. Dacic, A. Argiris, C. Belani, 2010, Clinical Cancer Research.

MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.

T. Godfrey, J. Luketich, A. Feber, 2011, The Annals of thoracic surgery.

Comparison of survival for non-small cell lung cancer (NSCLC) between premenopausal and postmenopausal women: An analysis of the National Surveillance, Epidemiology and End Results (SEER) Database.

T. Owonikoko, S. Ramalingam, W. Gooding, 2006, Journal of Clinical Oncology.

Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma

J. Kirkwood, S. Moschos, C. Sander, 2012, Journal of immunotherapy.

Point dose variations with time during traditional brachytherapy for cervical carcinoma.

S. Kalnicki, A. Wu, K. Gerszten, 2000, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Optimized Systemic Dosing with CpG DNA Enhances Dendritic Cell‐Mediated Rejection of a Poorly Immunogenic Mammary Tumor in BALB/c Mice

W. Gooding, Q. Cai, J. Baar, 2009, Clinical and translational science.

CpG methylation and reduced expression of O6-methylguanine DNA methyltransferase is associated with Helicobacter pylori infection.

D. Graham, A. Sepulveda, D. Park, 2010, Gastroenterology.

Induction docetaxel, cisplatin, and cetuximab (TPE) followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locoregionally advanced head and neck cancer (HNC): Mature results with HPV analysis.

D. Heron, R. Seethala, J. Grandis, 2010 .